DOI:
10.1055/s-00000030
Der Klinikarzt
LinksClose Window
References
Sands BE, Chen J, Feagan BG. et al
Efficacy and Safety of MEDI2070, an Antibody Against Interleukin 23, in Patients With Moderate to Severe Crohn’s Disease: A Phase 2a Study.
Gastroenterology 2017;
153: 77-86 e76
We do not assume any responsibility for the contents of the web pages of other providers.